Brief: Seres Therapeutics Q2 EPS USD 0.36
08/08/2023 12:00
Aug 08 (Reuters) - Seres Therapeutics Q2 collaboration revenue USD 126.473 million. * Q2 operating expenses USD 76.949 million * Q2 net income USD 46.552 million
Recent news on Seres Therapeutics
See all newsChinese automakers make tech-led pitch for Europe's premium car market
Brief: Seres Therapeutics - May Offer Up To $300 Million Of Securities
Seres Therapeutics, Inc. reports results for the quarter ended June 30 - Earnings Summary
Seres Therapeutics Q2 net income turns positive on VOWST sale gain
Brief: Seres Therapeutics Q2 EPS USD 0.47